Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation.

Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.

Inclusion Criteria:

• Diagnosis of glioblastoma multiforme
• No prior treatment for glioblastoma multiforme
• Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

• Female patients who are currently pregnant or nursing
• Enrolled in another research study
• Patients who are currently receiving any other investigational drug.

Patients with glioblastoma multiforme who are actively considering participating in an observational clinical study, but have not yet completed enrollment and randomization.